Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

No reported Weighted Avg Shares (Diluted) figures are available to summarize.

Weighted Avg Shares (Diluted) history

Shares · from the income statement

No Weighted Avg Shares (Diluted) data reported for this period type.

Weighted Avg Shares (Diluted) vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors Peer median
Weighted Avg Shares (Diluted) for KARD and competitors
Company Period LTM YoY 3-year CAGR
TNYATenaya Therapeutics, Inc.LTM Mar 2026158.02M +71.7%+50.6%
CYTKCytokinetics, IncorporatedLTM Jun 2026124.44M +5.1%+10.2%
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026119.47M +13.7%+82.0%
IKTInhibikase Therapeutics, Inc.LTM Mar 202694.17M +114.9%+186.0%
RNAAtrium Therapeutics, Inc.FY202517.11M ——
KARDKardigan, Inc.—— ——
Peer median (excluding KARD) 119.47M+42.7%+66.3%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.